Delivery of hormones: some new concepts
- 19 Downloads
Some new concepts in the delivery of hormones are described. Transmucosal or transdermal penetration of hormones can be facilitated, often by the use of absorption enhancers. Studies of nasal insulin delivery are described. Recently developed iontophoretic delivery devices can be useful for pulsatile transdermal administration of peptide hormones. A self-regulating delivery system releasing insulin in response to glucose levels is described. A vaginal ring relasing ethinylestradiol and 3-ketodesogestrel is a new concept in long-acting contraception. A nasal estradiol formulation, containing the absorption enhancer dimethyl-β-cyclodextrin, is an interesting alternative to oral and transdermal delivery of female sex hormones.
KeywordsContraceptive steroids Hormone delivery systems Insulin Oestrogen
Unable to display preview. Download preview PDF.
- 1.Verhoef JC, Boddé HE, De Boer AG, et al. Transport of peptide and protein drugs across biological membranes. Eur J Drug Metab Pharmacokinet 1990;15:83–93.Google Scholar
- 4.Collens WS, Goldzieher MA. Absorption of insulin by nasal mucous membrane. Proc Soc Exp Med 1932;29:756–8.Google Scholar
- 5.Hirai S, Yashiki T, Mima H. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int J Pharm 1981;9:173–84.Google Scholar
- 7.Lee VHL, Dodda Kashi S. Nasal peptide and protein absorption promotors: aminopeptidase inhibition as a predictor of absorption enhancement potency of bile salts. Proc Int Symp Control Rel Bioact Mater 1987;14:55–6.Google Scholar
- 10.Drejer K, Vaag A, Bech K, Hansen PE, Sorense AR, Mygind N. Pharmacokinetics of intranasally administered insulin with phospholipid as absorption enhancer. Diabetologica 1991;33 Suppl:A61.Google Scholar
- 11.Holman RR and Steemson J. Clinical trial of a new nasal insulin preparation. Diabetes 1991;40 Suppl:424A.Google Scholar
- 12.Chien YW, Lelawongs P, Siddique 0, Sun Y, Shi WM. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J Contr Rel 1990;13:263–78.Google Scholar
- 14.Chien YW, Banga AK. Potential developments in systemic delivery of insulin. Drug Devel Ind Pharm 1989;15:1601–34.Google Scholar
- 15.Heller J, Chang AC, Rodd G, Grodsky GM. Release of insulin from pH-sensative poly(ortho esters). J Contr Rel 1990;13:295–302.Google Scholar
- 16.Sam AP. Controlled-release contraceptive devices. In: Hincal AA, Kas S, Sumnu M, eds. Minutes 5th International Pharmaceutical Technology Symposium New approaches to the controlled drug delivery. Paris: Editions de Santé, 1991:271–84.Google Scholar